Compare Heron Therapeutics Inc (HRTX) vs Synopsys, Inc. (SNPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Synopsys, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Synopsys, Inc. trades at $390 (market cap $72.47B). The key difference: Synopsys, Inc. is far larger — about 792.4× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| HRTX | SNPS | |
|---|---|---|
Market Cap | $91.46M | $72.47B |
Sector | Health | Technology |
52-Week High | $1.96 | $645.59 |
52-Week Low | $0.39 | $378.46 |
Enterprise Value | $189.36M | $80.82B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Synopsys, Inc.
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →
